Xintela submits manufacturing license application

Lund, Sweden, 21 December 2020 – Xintela announces today that the company has submitted its application to the Swedish Medical Products Agency for a license to produce cell therapy products, also known as Advanced Therapy Medicinal Products (ATMPs), for clinical studies. Xintela has developed and patented the stem cell product platform XSTEM® and built its […]

Xintela recruits Jeffrey Abbey to Targinta

Lund, Sweden, 14 December 2020 -Xintela AB (publ) announces that Jeffrey Abbey has been recruited as a Senior Management Advisor to support further development of the wholly owned subsidiary Targinta. Mr. Abbey has more than 20 years of experience in the biopharmaceutical industry and has spent much of his career focused on the development of […]

Arbitral award rendered in favour of Xintela in dispute with former underwriters

Lund, Sweden, 4 December 2020 -Xintela AB (publ) announces that the arbitral tribunal today has rendered an arbitral award in the dispute between Xintela and four former underwriters. The arbitral award dismisses the claim for payment brought by the underwriters against Xintela in its entirety. The arbitral award concerns the dispute that arose in connection […]

Xintela Board recommends Maarten de Château as new Board member

Lund, Sweden, 3 December 2020 -Xintela AB (publ) announces that Maarten de Château has accepted an invitation to join the Xintela Board of Directors. The Xintela Board will recommend that shareholders formally appoint Maarten at the next shareholders meeting. In the meantime, Maarten will be adjoined to future Board meetings. Maarten de Château is currently […]

Xintela Board recommends Lars Hedbys as new Board member

Lund, Sweden, 12 November 2020 -Xintela AB (publ) announces that Lars Hedbys has accepted an invitation to join the Xintela Board of Directors.  The Xintela Board will recommend that shareholders formally appoint Lars at the next shareholders meeting. In the meantime, Lars will be adjoined to future Board meetings. Lars Hedbys (born 1957) has significant […]

Xintela applies for tissue establishment license

Lund, Sweden, 28 October 2020 – Xintela announces today that the company has submitted an application to the Medical Products Agency for a tissue establishment license for handling tissues and cells for manufacturing of medicinal products. In order to be allowed to conduct activities that handle human tissues and cells for the manufacture of medicinal […]

Xintela’s stem cells show promising results in preclinical ARDS study

Lund, Sweden, 26 October 2020 – Xintela announces today that the company’s selected human stem cells XSTEM® show a therapeutic effect in ARDS (Acute Respiratory Distress Syndrome) in an ongoing preclinical study in pigs. ARDS is a life-threatening lung complication that may affect severely ill covid-19 patients. Xintela previously announced that XSTEM-ARDS is being evaluated […]

Xintela expands and strengthens management team

Lund, Sweden, August 19, 2020 – Xintela announces it is expanding and strengthening its management team with Peter Ekolind as COO (Chief Operating Officer) and Thomas Areschoug as CBO (Chief Business Officer). Sven Kili, who has had a combined role as COO and CMO (Chief Medical Officer), will focus on his role as CMO. “As […]